Brown Brothers Harriman & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Buy |
5,039
+134
| +3% | +$11.1K | ﹤0.01% | 490 |
|
|
2025
Q1 | $398K | Hold |
4,905
| – | – | ﹤0.01% | 434 |
|
|
2024
Q4 | $442K | Hold |
4,905
| – | – | ﹤0.01% | 427 |
|
|
2024
Q3 | $485K | Hold |
4,905
| – | – | ﹤0.01% | 408 |
|
|
2024
Q2 | $455K | Hold |
4,905
| – | – | ﹤0.01% | 391 |
|
|
2024
Q1 | $465K | Hold |
4,905
| – | – | ﹤0.01% | 368 |
|
|
2023
Q4 | $438K | Hold |
4,905
| – | – | ﹤0.01% | 368 |
|
|
2023
Q3 | $358K | Hold |
4,905
| – | – | ﹤0.01% | 387 |
|
|
2023
Q2 | $408K | Hold |
4,905
| – | – | ﹤0.01% | 357 |
|
|
2023
Q1 | $374K | Hold |
4,905
| – | – | ﹤0.01% | 381 |
|
|
2022
Q4 | $407K | Hold |
4,905
| – | – | ﹤0.01% | 346 |
|
|
2022
Q3 | $389K | Hold |
4,905
| – | – | ﹤0.01% | 342 |
|
|
2022
Q2 | $364K | Buy |
4,905
+2,700
| +122% | +$200K | ﹤0.01% | 364 |
|
|
2022
Q1 | $198K | Buy |
+2,205
| New | +$198K | ﹤0.01% | 510 |
|
|
2020
Q1 | – | Sell |
-83
| Closed | -$8K | – | 1320 |
|
|
2019
Q4 | $8K | Sell |
83
-83
| -50% | -$8K | ﹤0.01% | 922 |
|
|
2019
Q3 | $13K | Buy |
+166
| New | +$13K | ﹤0.01% | 857 |
|
|
2018
Q4 | – | Sell |
-90
| Closed | -$9K | – | 1003 |
|
|
2018
Q3 | $9K | Buy |
+90
| New | +$9K | ﹤0.01% | 696 |
|